Showing results (1-10 of 516) with videos related to
Sort By:
Pageof 52
Annals of Internal Medicine|February 1, 2021
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19Sameer Sharif, Bram RochwergAnnals of Internal Medicine|October 3, 2022
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survivalAlexandre Tran, Bram RochwergAnnals of Internal Medicine|January 31, 2022
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleedingDipayan Chaudhuri, Bram RochwergAnnals of Internal Medicine|May 31, 2021
In COVID-19, tocilizumab reduces all-cause mortality at 28 dShannon M Fernando, Bram RochwergCurrent Opinion in Critical Care|July 7, 2021
How trustworthy guidelines can impact outcomesBram Rochwerg, Leticia Kawano-Dourado, Nida QadirBMC Medicine|February 11, 2016
Idiopathic pulmonary fibrosis - clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development?Bram Rochwerg, Holger J Schünemann, Ganesh RaghuJournal of Palliative Medicine|December 29, 2017
Resources for Educating, Training, and Mentoring All Physicians Providing Palliative CareJames DownarCritical Care (London, England)|August 12, 2009
Even without our biases, the outlook for prognostication is grimJames DownarCritical Care Explorations|April 3, 2023
High-Flow Nasal Cannula Compared With Noninvasive Positive Pressure Ventilation in Acute Hypoxic Respiratory Failure: A Systematic Review and Meta-AnalysisDipayan Chaudhuri, Vatsal Trivedi, Kimberley Lewis, et al.Pageof 52